Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSeptâ„¢ ASD Occluder
Company prepares for U.S. IDE clinical trial of its novel metal-free frame designed to reduce complications and preserve long-term treatment options The company's first product, the reSept ASD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results